Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 2/2015

01.02.2015 | Original Paper

Effects of cardiac resynchronization therapy on left ventricular remodeling and dyssynchrony in patients with left ventricular noncompaction and heart failure

verfasst von: Qiong Qiu, Yang-xin Chen, Jing-ting Mai, Wo-liang Yuan, Yu-lin Wei, Ying-mei Liu, Li Yang, Jing-feng Wang

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Left ventricular noncompaction (LVNC) is a rare cardiomyopathy with high incidence of heart failure (HF). It is unclear whether LVNC patients with desynchronized HF would benefit from cardiac resynchronization therapy (CRT). In order to evaluate the effect of CRT on LVNC, this study explored left ventricular (LV) remodeling and mechanical synchronicity before and after CRT in LVNC patients, and compare with that in idiopathic dilated cardiomyopathy (DCM) patients. We collected 15 LVNC and 30 matched DCM patients. All the patients underwent clinical evaluation,electrocardiogram and echocardiography before CRT and ≥6 months later. LV response was defined as ≥15 % decrease in LV end-systolic volume (LVESV). Longitudinal synchronicity was quantified by YU-index using tissue Doppler imaging. The time delay of peak radial strain from anteroseptal to posterior wall, which derived from speckle tracking imaging, was used to quantify radial synchronicity. In LVNC group, LV ejection fraction increased from 27.6 ± 5.5 to 39.1 ± 7.0 % (P < 0.01) during follow-up, but LV volumes did not change significantly (both P > 0.05). Five LVNC patients (33.3 %) responded to CRT, and all of them were super-responders (reduction in LVESV > 30 %). In addition, the number of noncompacted segments and the thickness ratio of noncompacted to compacted myocardium decreased (both P < 0.05). Inter-ventricular, longitudinal and radial intra-ventricular dyssynchrony also reduced significantly (all P < 0.05). Compared with DCM group, there was no significant difference in LV response rate (33.3 vs. 60.0 %, P = 0.092), improvement of LV function and dyssynchrony index (all P < 0.05). In conclusion, CRT improved heart function, morphology and mechanical dyssynchrony in LVNC patients.
Literatur
2.
Zurück zum Zitat Elliott P, Andersson B, Arbustini E et al (2008) Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29:270–276. doi:10.1093/eurheartj/ehm342 CrossRefPubMed Elliott P, Andersson B, Arbustini E et al (2008) Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29:270–276. doi:10.​1093/​eurheartj/​ehm342 CrossRefPubMed
3.
Zurück zum Zitat Cheng H, Zhao S, Jiang S et al (2011) Cardiac magnetic resonance imaging characteristics of isolated left ventricular noncompaction in a Chinese adult Han population. Int J Cardiovasc Imaging 27:979–987. doi:10.1007/s10554-010-9741-x CrossRefPubMed Cheng H, Zhao S, Jiang S et al (2011) Cardiac magnetic resonance imaging characteristics of isolated left ventricular noncompaction in a Chinese adult Han population. Int J Cardiovasc Imaging 27:979–987. doi:10.​1007/​s10554-010-9741-x CrossRefPubMed
4.
Zurück zum Zitat Stollberger C, Winkler-Dworak M, Blazek G et al (2007) Association of electrocardiographic abnormalities with cardiac findings and neuromuscular disorders in left ventricular hypertrabeculation/non-compaction. Cardiology 107:374–379. doi:10.1159/000099055 CrossRefPubMed Stollberger C, Winkler-Dworak M, Blazek G et al (2007) Association of electrocardiographic abnormalities with cardiac findings and neuromuscular disorders in left ventricular hypertrabeculation/non-compaction. Cardiology 107:374–379. doi:10.​1159/​000099055 CrossRefPubMed
6.
Zurück zum Zitat Yancy CW, Jessup M, Bozkurt B et al (2013) 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 128:e240–e319. doi:10.1161/CIR.0b013e31829e8776 CrossRefPubMed Yancy CW, Jessup M, Bozkurt B et al (2013) 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 128:e240–e319. doi:10.​1161/​CIR.​0b013e31829e8776​ CrossRefPubMed
7.
Zurück zum Zitat Barsheshet A, Goldenberg I, Moss AJ et al (2011) Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT. Eur Heart J 32:1622–1630. doi:10.1093/eurheartj/ehq407 CrossRefPubMed Barsheshet A, Goldenberg I, Moss AJ et al (2011) Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT. Eur Heart J 32:1622–1630. doi:10.​1093/​eurheartj/​ehq407 CrossRefPubMed
8.
Zurück zum Zitat Brignole M, Auricchio A, Baron-Esquivias G et al (2013) 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 34:2281–2329. doi:10.1093/eurheartj/eht150 CrossRefPubMed Brignole M, Auricchio A, Baron-Esquivias G et al (2013) 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 34:2281–2329. doi:10.​1093/​eurheartj/​eht150 CrossRefPubMed
9.
Zurück zum Zitat Epstein AE, DiMarco JP, Ellenbogen KA et al (2013) 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 61:e6–e75. doi:10.1016/j.jacc.2012.11.007 CrossRefPubMed Epstein AE, DiMarco JP, Ellenbogen KA et al (2013) 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 61:e6–e75. doi:10.​1016/​j.​jacc.​2012.​11.​007 CrossRefPubMed
13.
Zurück zum Zitat Jenni R, Oechslin E, Schneider J et al (2001) Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart 86:666–671CrossRefPubMedCentralPubMed Jenni R, Oechslin E, Schneider J et al (2001) Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart 86:666–671CrossRefPubMedCentralPubMed
14.
Zurück zum Zitat van Bommel RJ, Bax JJ, Abraham WT et al (2009) Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis. Eur Heart J 30:2470–2477. doi:10.1093/eurheartj/ehp368 CrossRefPubMed van Bommel RJ, Bax JJ, Abraham WT et al (2009) Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis. Eur Heart J 30:2470–2477. doi:10.​1093/​eurheartj/​ehp368 CrossRefPubMed
15.
Zurück zum Zitat Gorcsan JR, Abraham T, Agler DA et al (2008) Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting–a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society. J Am Soc Echocardiogr 21:191–213. doi:10.1016/j.echo.2008.01.003 CrossRefPubMed Gorcsan JR, Abraham T, Agler DA et al (2008) Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting–a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society. J Am Soc Echocardiogr 21:191–213. doi:10.​1016/​j.​echo.​2008.​01.​003 CrossRefPubMed
16.
Zurück zum Zitat Daubert JC, Saxon L, Adamson PB et al (2012) 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Europace 14:1236–1286. doi:10.1093/europace/eus222 CrossRefPubMed Daubert JC, Saxon L, Adamson PB et al (2012) 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Europace 14:1236–1286. doi:10.​1093/​europace/​eus222 CrossRefPubMed
17.
Zurück zum Zitat Habib G, Charron P, Eicher JC et al (2011) Isolated left ventricular non-compaction in adults: clinical and echocardiographic features in 105 patients. Results from a French registry. Eur J Heart Fail 13:177–185. doi:10.1093/eurjhf/hfq225 CrossRefPubMed Habib G, Charron P, Eicher JC et al (2011) Isolated left ventricular non-compaction in adults: clinical and echocardiographic features in 105 patients. Results from a French registry. Eur J Heart Fail 13:177–185. doi:10.​1093/​eurjhf/​hfq225 CrossRefPubMed
18.
Zurück zum Zitat Stollberger C, Blazek G, Wegner C et al (2011) Heart failure, atrial fibrillation and neuromuscular disorders influence mortality in left ventricular hypertrabeculation/noncompaction. Cardiology 119:176–182. doi:10.1159/000331496 CrossRefPubMed Stollberger C, Blazek G, Wegner C et al (2011) Heart failure, atrial fibrillation and neuromuscular disorders influence mortality in left ventricular hypertrabeculation/noncompaction. Cardiology 119:176–182. doi:10.​1159/​000331496 CrossRefPubMed
22.
Zurück zum Zitat Steffel J, Milosevic G, Hurlimann A et al (2011) Characteristics and long-term outcome of echocardiographic super-responders to cardiac resynchronisation therapy: ‘real world’ experience from a single tertiary care centre. Heart 97:1668–1674. doi:10.1136/heartjnl-2011-300222 CrossRefPubMed Steffel J, Milosevic G, Hurlimann A et al (2011) Characteristics and long-term outcome of echocardiographic super-responders to cardiac resynchronisation therapy: ‘real world’ experience from a single tertiary care centre. Heart 97:1668–1674. doi:10.​1136/​heartjnl-2011-300222 CrossRefPubMed
23.
24.
Zurück zum Zitat Jenni R, Wyss CA, Oechslin EN et al (2002) Isolated ventricular noncompaction is associated with coronary microcirculatory dysfunction. J Am Coll Cardiol 39:450–454CrossRefPubMed Jenni R, Wyss CA, Oechslin EN et al (2002) Isolated ventricular noncompaction is associated with coronary microcirculatory dysfunction. J Am Coll Cardiol 39:450–454CrossRefPubMed
26.
Zurück zum Zitat Kyriacou A, Whinnett ZI, Sen S et al (2012) Improvement in coronary blood flow velocity with acute biventricular pacing is predominantly due to an increase in a diastolic backward-travelling decompression (suction) wave. Circulation 126:1334–1344. doi:10.1161/CIRCULATIONAHA.111.075606 CrossRefPubMed Kyriacou A, Whinnett ZI, Sen S et al (2012) Improvement in coronary blood flow velocity with acute biventricular pacing is predominantly due to an increase in a diastolic backward-travelling decompression (suction) wave. Circulation 126:1334–1344. doi:10.​1161/​CIRCULATIONAHA.​111.​075606 CrossRefPubMed
28.
29.
Zurück zum Zitat Faber L, Vlachojannis M, Oldenburg O et al (2012) Long-term follow-up of cardiac resynchronization therapy: mechanical resynchronization and reverse left ventricular remodeling are predictive for long-term transplant-free survival. Int J Cardiovasc Imaging 28:1341–1350. doi:10.1007/s10554-011-9946-7 CrossRefPubMed Faber L, Vlachojannis M, Oldenburg O et al (2012) Long-term follow-up of cardiac resynchronization therapy: mechanical resynchronization and reverse left ventricular remodeling are predictive for long-term transplant-free survival. Int J Cardiovasc Imaging 28:1341–1350. doi:10.​1007/​s10554-011-9946-7 CrossRefPubMed
30.
31.
Zurück zum Zitat Wasmer K, Kobe J, Andresen D et al (2013) Comparing outcome of patients with coronary artery disease and dilated cardiomyopathy in ICD and CRT recipients: data from the German DEVICE-registry. Clin Res Cardiol 102:513–521. doi:10.1007/s00392-013-0559-0 CrossRefPubMed Wasmer K, Kobe J, Andresen D et al (2013) Comparing outcome of patients with coronary artery disease and dilated cardiomyopathy in ICD and CRT recipients: data from the German DEVICE-registry. Clin Res Cardiol 102:513–521. doi:10.​1007/​s00392-013-0559-0 CrossRefPubMed
Metadaten
Titel
Effects of cardiac resynchronization therapy on left ventricular remodeling and dyssynchrony in patients with left ventricular noncompaction and heart failure
verfasst von
Qiong Qiu
Yang-xin Chen
Jing-ting Mai
Wo-liang Yuan
Yu-lin Wei
Ying-mei Liu
Li Yang
Jing-feng Wang
Publikationsdatum
01.02.2015
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 2/2015
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-014-0568-8

Weitere Artikel der Ausgabe 2/2015

The International Journal of Cardiovascular Imaging 2/2015 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.